Cancer and fertility preservation: Fertility preservation in breast cancer patients

Breast Cancer Research

Volumn 10, Issue 2, 2008, Pages

  Maltaris, Theodoros ^a,b   Weigel, Michael ^b   Mueller, Andreas ^c   Schmidt, Marcus ^a   Seufert, Rudolf ^a   Fischl, Franz ^a   Koelbl, Heinz ^a   Dittrich, Ralf ^c  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Department of Obstetrics and Gynecology   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AMENORRHEA; ANIMAL; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CRYOPRESERVATION; EARLY MENOPAUSE; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INCIDENCE; INFERTILITY THERAPY; OOCYTE; PREDICTION AND FORECASTING; PREGNANCY; PREGNANCY COMPLICATION; PROGNOSIS; REVIEW; SURVIVOR;

AMENORRHEA; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CRYOPRESERVATION; FEMALE; FERTILIZATION IN VITRO; HUMANS; INCIDENCE; INFERTILITY, FEMALE; MENOPAUSE, PREMATURE; OOCYTES; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROGNOSIS; REPRODUCTIVE TECHNIQUES, ASSISTED; SURVIVORS;

EID: 48949119474     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1991     Document Type: Review

References (90)

1. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK. SEER Cancer Statistics Review, 1975-2001 Bethesda, MD: National Cancer Institute., http://seer.cancer.gov/csr/1975_2001
2. Loibl S, Kohl J, Kaufmann M. Reproduction after breast cancer: what advice do we have for our patients? [In German]. Zentralbl Gynakol 2005, 127:120-124. 10.1055/s-2005-836481, 15915388.
3. Maltaris T, Boehm D, Dittrich R, Seufert R, Koelbl H. Reproduction beyond cancer: a message of hope for young women. Gynecol Oncol 2006, 103:1109-1121. 10.1016/j.ygyno.2006.08.003, 16996582.
4. Goldhirsch A, Gelber RD, Castiglione M. The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group. Ann Oncol 1990, 1:183-188.
5. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996, 14:1718-1729.
6. Levine MN, Bramwell VH, Pritchard KI, Norris BD, Shepherd LE, Abu-Zahra H, Findlay B, Warr D, Bowman D, Myles J, Arnold A, Vandenberg T, MacKenzie R, Robert J, Ottaway J, Burnell M, Williams CK, Tu D. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1998, 16:2651-2658.
7. Goodwin PJ, Ennis M, Pritchard KI, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999, 17:2365-2370.
8. Nabholtz J, Pienkowski T, Mackey J. Phase III trial comparing TAC (docetaxel, doxorubicin, cyclophosphamide) with FAC (5-fluorouracil, doxorubicin, cyclophosphamide) in the adjuvant treatment of node positive breast cancer (BC) patients: interim analysis of the BCIRG 0001 study. Proc Am Soc Clin Oncol 2002, 21:36a.
9. Fornier MN, Modi S, Panageas KS, Norton L, Hudis C. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 2005, 104:1575-1579. 10.1002/cncr.21385, 16134178.
10. Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Weaver C, Tomiak E, Al-Tweigeri T, Chap L, Juhos E, . Breast Cancer International Research Group 001 Investigators Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 2005, 352:2302-2313. 10.1056/NEJMoa043681, 15930421, Breast Cancer International Research Group 001 Investigators.
11. Venturini M, Del Mastro L, Aitini E, Baldini E, Caroti C, Contu A, Testore F, Brema F, Pronzato P, Cavazzini G, Sertoli MR, Canavese G, Rosso R, Bruzzi P. Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial. J Natl Cancer Inst 2005, 97:1724-1733.
12. Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, Sukumvanich P. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 2006, 24:1045-1051. 10.1200/JCO.2005.03.3969, 16476708.
13. Tham YL, Sexton K, Weiss H, Elledge R, Friedman LC, Kramer R. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol 2007, 30:126-132. 10.1097/01.coc.0000251398.57630.4f, 17414460.
14. Minton SE, Munster PN. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer Control 2002, 9:466-472.
15. Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hematooncological neoplasias and other cancers. Leuk Lymphoma 1999, 33:65-76.
16. Davis AL, Klitus M, Mintzer DM. Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes. Clin Breast Cancer 2005, 6:421-424.
17. Kramer R, Tham YL, Sexton K. Chemotherapy-induced amenorrhea is increased in patients treated with adjuvant doxorubicin and cyclophosphamide (AC) followed by a taxane (T). ASCO annual meeting proceedings. J Clin Oncol 2005, 23:651.
18. Abusief ME, Missmer SA, Ginsburg ES. Chemotherapy-related amenorrhea in women with early breast cancer: the effect of paclitaxel or dose density. ASCO annual meeting proceedings (post-meeting edition). J Clin Oncol 2006, 24:105-106.
19. Stern CJ, Toledo MG, Gook DA, Seymour JF. Fertility preservation in female oncology patients. Aust N Z J Obstet Gynaecol 2006, 46:15-23. 10.1111/j.1479-828X.2006.00507.x, 16441687.
20. Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol 2005, 17:299-308.
21. Maltaris T, Seufert R, Fischl F, Schaffrath M, Pollow K, Koelbl H, Dittrich R. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol 2007, 130:148-155. 10.1016/j.ejogrb.2006.08.006, 16979280.
22. Pickering SJ, Braude PR, Johnson MH, Cant A, Currie J. Transient cooling to room temperature can cause irreversible disruption of the meiotic spindle in the human oocyte. Fertil Steril 1990, 54:102-108.
23. Gook DA, Osborn SM, Bourne H, Johnston WI. Fertilization of human oocytes following cryopreservation: normal karyotypes and absence of stray chromosomes. Hum Reprod 1994, 9:684-691.
24. Gosden RG. Prospects for oocyte banking and in vitro maturation. J Natl Cancer Inst Monogr 2005, 34:60-63. 10.1093/jncimonographs/lgi007, 15784826.
25. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 2006, 86:70-80. 10.1016/j.fertnstert.2006.03.017, 16818031.
26. Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod 2000, 15:165-170. 10.1093/humrep/15.1.165, 10611207.
27. Fox KR, Scialla J, Moore H. Preventing chemotherapy-related amenorrhea using leuprolide during adjuvant chemotherapy for early-stage breast cancer [abstract 50]. Proc Am Soc Clin Oncol 2003, 22:13.
28. Del Mastro L, Catzeddu T, Boni L, Bell C, Sertoli MR, Bighin C, Clavarezza M, Testa D, Venturini M. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol 2006, 17:74-78. 10.1093/annonc/mdj029, 16254024.
29. Recchia F, Sica G, De Filippis S, Saggio G, Rosselli M, Rea S. Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study. Anti-cancer Drugs 2002, 13:417-424. 10.1097/00001813-200204000-00011, 11984088.
30. Urruticoechea A, Arnedos M, Walsh G, Dowsett M, Smith IE. Ovarian protection with goserelin during adjuvant chemotherapy for premenopausal women with early breast cancer (EBC). Breast Cancer Res Treat 2007, [doi 10.1007/s10549-007-9745-y]..
31. Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist 2007, 12:1044-1054. 10.1634/theoncologist.12-9-1044, 17914074.
32. Oktay K, Sonmezer M, Oktem O, Fox K, Emons G, Bang H. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 2007, 12:1055-1066. 10.1634/theoncologist.12-9-1055, 17914075.
33. Emons G, Grundker C, Gunthert AR, Westphalen S, Kavanagh J, Verschraegen C. GnRH antagonists in the treatment of gynecological and breast cancers. Endocr Relat Cancer 2003, 10:291-299. 10.1677/erc.0.0100291, 12790790.
34. Cuzick J, Ambroisine L, Davidson N, Jakesz R, Kaufmann M, Regan M, Sainsbury R. LHRH-agonists in Early Breast Cancer Overview group Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet 2007, 369:1711-1723. 10.1016/S0140-6736(07)60778-8, 17512856, LHRH-agonists in Early Breast Cancer Overview group.
35. Howell A. Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer [abstract]. Breast Cancer Res 2007, 9(Suppl 1):S12.
36. Del Mastro L, Venturini M, Sertoli MR, Rosso R. Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications. Breast Cancer Res Treat 1997, 43:183-190. 10.1023/A:1005792830054, 9131274.
37. Dawood MY, Ramos J, Khan-Dawood FS. Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin. Fertil Steril 1995, 63:1177-1783.
38. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K, . American Society of Clinical Oncology American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006, 24:2917-2931. 10.1200/JCO.2006.06.5888, 16651642, American Society of Clinical Oncology.
39. Maltaris T, Koelbl H, Seufert R, Kiesewetter F, Beckmann MW, Müller A, Dittrich R. Gonadal damage and options for fertility preservation in female and male cancer survivors. Asian J Androl 2006, 8:515-533. 10.1111/j.1745-7262.2006.00206.x, 16847527.
40. Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, Schiff E, Dor J. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005, 353:318-321. 10.1056/NEJMc055237, 15983020.
41. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004, 364:1405-1410. 10.1016/S0140-6736(04)17222-X, 15488215.
42. Oktay K, Newton H, Aubard Y, Salha O, Gosden RG. Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology?. Fertil Steril 1998, 69:1-7. 10.1016/S0015-0282(97)00207-0, 9457923.
43. Simon B, Lee SJ, Partridge AH, Runowicz CD. Preserving fertility after cancer. CA Cancer J Clin 2005, 55:211-228.
44. Sonmezer M, Shamonki MI, Oktay K. Ovarian tissue cryopreservation: benefits and risks. Cell Tissue Res 2005, 322:125-132. 10.1007/s00441-005-1098-4, 15912406.
45. Maltaris T, Koelbl H, Fischl F, Seufert R, Schmidt M, Kohl J, Beckmann MW, Binder H, Hoffmann I, Müller A, Dittrich R. Xenotrans-plantation of human ovarian tissue pieces in gonadotropin-stimulated SCID mice: the effect of ovariectomy. Anticancer Res 2006, 26:4171-4176.
46. Maltaris T, Kaya H, Hoffmann I, Müller A, Beckmann MW, Dittrich R. Comparison of xenografting in SCID mice and LIVE/DEAD assay as a predictor of the developmental potential of cryopreserved ovarian tissue. In Vivo 2006, 20:11-16.
47. Maltaris T, Beckmann MW, Müller A, Hoffmann I, Kohl J, Dittrich R. Significant loss of primordial follicles after prolonged gonadotropin stimulation in xenografts of cryopreserved human ovarian tissue in severe combined immunodeficient mice. Fertil Steril 2007, 87:195-197. 10.1016/j.fertnstert.2006.05.058, 17074335.
48. Maltaris T, Beckmann MW, Binder H, Müller A, Hoffmann I, Koelbl H, Dittrich R. The effect of a GnRH agonist on cryopreserved human ovarian grafts in severe combined immunodeficient mice. Reproduction 2007, 133:503-509. 10.1530/REP-06-0061, 17307918.
49. Santen RJ, Song RX, Zhang, Kumar R, Jeng MH, Masamura S, Lawrence J, McMahon LP, Yue W, Berstein L. Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment. J Steroid Biochem Mol Biol 2005, 95:155-165. 10.1016/j.jsbmb.2005.04.025, 16024245.
50. Masamura S, Santner SJ, Heitjan DF, Santen RJ. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 1995, 80:2918-2925. 10.1210/jc.80.10.2918, 7559875.
51. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005, 23:4347-4353. 10.1200/JCO.2005.05.037, 15824416.
52. Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003, 18:90-95. 10.1093/humrep/deg045, 12525446.
53. Sonmezer M, Oktay K. Fertility preservation in young women undergoing breast cancer therapy. The Oncologist 2006, 11:422-434. 10.1634/theoncologist.11-5-422, 16720842.
54. Cudmore DW, Tupper WR. Induction of ovulation with clomiphene citrate. A double-blind study. Fertil Steril 1966, 17:363-373.
55. Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, Sahmoud T, . ATAC Trialists' Group Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial. Lancet 2002, 359:2131-2139. 10.1016/S0140-6736(02)09088-8, 12090977, ATAC Trialists' Group.
56. Thurlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M, Smith I, Wardly A, Price KN, Goldhirsch A. Breast International Group (BIG) 1-98 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 2005, 353:2747-2757. 10.1056/NEJMoa052258, 16382061.
57. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001, 75:305-309. 10.1016/S0015-0282(00)01705-2, 11172831.
58. Falcone T, Bedaiwy MA. Fertility preservation and pregnancy outcome after malignancy. Curr Opin Obstet Gynecol 2005, 17:21-26.
59. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006, 91:3885-3890. 10.1210/jc.2006-0962, 16882752.
60. Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 2007, 92:2197-2200. 10.1210/jc.2007-0247, 17356042.
61. Partridge AH, Winer EP. Fertility after breast cancer: questions abound. J Clin Oncol 2005, 23:4259-4261. 10.1200/JCO.2005.12.914, 15824413.
62. Ariel IM, Kempner R. The prognosis of patients who become pregnant after mastectomy for breast cancer. Int Surg 1989, 74:185-187.
63. Sutton R, Buzdar AU, Hortobagyi GN. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer 1990, 65:847-850. 10.1002/1097-0142(19900215)65:4<847::AID-CNCR2820650402>3.0.CO;2-A, 2297653.
64. Sankila R, Heinavaara S, Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: 'healthy mother effect'. Am J Obstet Gynecol 1994, 170:818-823.
65. von Schoultz E, Johansson H, Wilking N, Rutqvist LE. Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 1995, 13:430-434.
66. Malamos NA, Stathopoulos GP, Keramopoulos A, Papadiamantis J, Vassilaros S. Pregnancy and offspring after the appearance of breast cancer. Oncology 1996, 53:471-475.
67. Kroman N, Jensen MB, Melbye M, Wohlfahrt J, Mouridsen HAT. Should women be advised against pregnancy after breast-cancer treatment?. Lancet 1997, 350:319-322. 10.1016/S0140-6736(97)03052-3, 9251635.
68. Velentgas P, Daling JR, Malone KE, Weiss NS, Williams MA, Self SG, Müller BA. Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 1999, 85:2424-2432. 10.1002/(SICI)1097-0142(19990601)85:11<2424::AID-CNCR17>3.0.CO;2-4, 10357413.
69. Gelber S, Coates AS, Goldhirsch A, Castiglione-Gertsch M, Marini G, Lindtner J, Edelmann DZ, Gudgeon A, Harvey V, Gelber RD, . International Breast Cancer Study Group Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. International Breast Cancer Study Group. J Clin Oncol 2001, 19:1671-1675. International Breast Cancer Study Group.
70. Müller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR. Childbearing and survival after breast carcinoma in young women. Cancer 2003, 98:1131-1140. 10.1002/cncr.11634, 12973836.
71. Blakely LJ, Buzdar AU, Lozada JA, Shullaih SA, Hoy E, Smith TL, Hortobagyi GN. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 2004, 100:465-469. 10.1002/cncr.11929, 14745861.
72. Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: population based study. BMJ 2007, 334:194. 1781958, 17158581, 10.1136/bmj.39035.667176.55.
73. Partridge AH, Ruddy KJ. Fertility and adjuvant treatment in young women with breast cancer. Breast 2007, (Suppl 2):S175-S181.
74. Yuri T, Tsukamoto R, Uehara N, Matsuoka Y, Tsubura A. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. In Vivo 2006, 20:829-836.
75. Tsukamoto R, Mikami T, Miki K, Uehara N, Yuri T, Matsuoka Y, Okazaki K, Tsubura A. N-methyl-N-nitrosourea-induced mammary carcinogenesis is promoted by short-term treatment with estrogen and progesterone mimicking pregnancy in aged female Lewis rats. Oncol Rep 2007, 18:337-342.
76. Meirow D, Schiff E. Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data. J Natl Cancer Inst Monogr 2005, 34:21-25. 10.1093/jncimonographs/lgi025, 15784816.
77. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000, 342:1878-1886. 10.1056/NEJM200006223422506, 10861324.
78. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000, 342:1887-1892. 1557642, 10861325, 10.1056/NEJM200006223422507.
79. Gerber B, Dieterich M, Muller H, Reimer T. Controversies in preservation of ovary function and fertility in patients with breast cancer. Breast Cancer Res Treat 2008, 108:1-7. 10.1007/s10549-007-9572-1, 17457668.
80. Borde F, Chapelle-Marcilac IFP, Hery M. Role of chemo-induced amenorrhea in premenopausal, node-positive, operable breast cancer patients: 9-year follow-up results of French Adjuvant Study Group (FASG) database [abstract]. Breast Cancer Res Treat 2003, 82:30.
81. Gnant M, Greil R, Kubista E. The impact of treatment-induced amenorrhea on survival of premenopausal patients with endocrine responsive breast cancer: 10-year result of ABCSG-05 (CMF vs. goserelin + tamoxifen) [abstract]. Breast Cancer Res Treat 2006, 100:10.
82. Pritchard KI. Adjuvant therapy for premenopausal women with breast cancer: is it time for another paradigm shift?. J Clin Oncol 2002, 20:4611-4614.
83. Baum M, Shah E. GnRH analogues in the management of early breast cancer. Breast Cancer Online 2001, 4., http://www.bco.org
84. Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y. cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 1977, 39:1403-1409. 10.1002/1097-0142(197704)39:4<1403::AID-CNCR2820390408>3.0.CO;2-8, 851940.
85. Mehta RR, Beattie CW, Das Gupta TK. Endocrine profile in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 1992, 20:125-132. 10.1007/BF01834642, 1554888.
86. Poikonen P, Saarto T, Elomaa I, Joensuu H, Blomqvist C. Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients. Eur J Cancer 2000, 36:43-48. 10.1016/S0959-8049(99)00225-7, 10741293.
87. Pagani O, O'Neill A, Castiglione M, Gelber RD, Goldhirsch A, Rudenstam CM, Lindtner J, Collins J, Crivellari D, Coates A, Cavalli F, Thurlimann B, Simoncini E, Fey M, Price K, Senn HJ. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) trial VI. Eur J Cancer 1998, 34:632-640. 10.1016/S0959-8049(97)10036-3, 9713266.
88. Del Mastro L, Catzeddu T, Venturini M. Infertility and pregnancy after breast cancer: current knowledge and future perspectives. Cancer Treat Rev 2006, 32:417-422. 10.1016/j.ctrv.2006.05.004, 16842927.
89. Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 2006, 24:5769-5779. 10.1200/JCO.2006.07.2793, 17130515.
90. Cuzick J. The impact of LHRH agonists on breast cancer recurrence and mortality: an overview of the randomized trials. Breast Cancer Res Treat 2006, 100(Suppl 1):10.